Display title | Medicine:Allergic bronchopulmonary aspergillosis |
Default sort key | Allergic bronchopulmonary aspergillosis |
Page length (in bytes) | 39,503 |
Namespace ID | 3048 |
Namespace | Medicine |
Page ID | 916493 |
Page content language | en - English |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Counted as a content page | Yes |
Page image |  |
HandWiki item ID | None |
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Page creator | imported>Steve2012 |
Date of page creation | 02:27, 5 February 2024 |
Latest editor | imported>Steve2012 |
Date of latest edit | 02:27, 5 February 2024 |
Total number of edits | 1 |
Recent number of edits (within past 90 days) | 0 |
Recent number of distinct authors | 0 |
Description | Content |
Article description: (description ) This attribute controls the content of the description and og:description elements. | Allergic bronchopulmonary aspergillosis (ABPA) is a condition characterised by an exaggerated response of the immune system (a hypersensitivity response) to the fungus Aspergillus (most commonly Aspergillus fumigatus). It occurs most often in people with asthma or cystic fibrosis. Aspergillus spores... |